Tag: OGI.TO

CannabisNewsBreaks – Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Boosts Consumer Access to Quality Medical Cannabis Products via Supply Agreement

Organigram Holdings (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced that it has entered a supply agreement with Medical Cannabis by Shoppers, the online medical cannabis platform by Shoppers Drug Mart Inc. The agreement, which is comprised of a three-year term subject to renewal for an additional two years, highlights Organigram’s commitment to provide Canadian consumers access to quality medical cannabis products. Per the terms of the agreement, Organigram will provide Shoppers with a broad array of products such as dried flower, oils and other products as they become available in the future. “We are extremely proud to partner with Shoppers and believe that our complementary approach to the medical cannabis market will offer the full strength of our combined national networks to Canadian patients,” Organigram Holdings Senior Vice President of Sales and Commercial Operations Tim Emberg stated in the news release. “We are pleased that we will now be able to offer medical cannabis patients across the country even greater access to our growing portfolio of high-quality products.”

To view the full press release, visit http://cnw.fm/IbmT3

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).  For more information, visit the company’s website at www.Organigram.ca.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Recognized Among Atlantic Canada’s Top 100 Employers

Organigram Holdings (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced it has been selected as one of Atlantic Canada’s Top Employers. According to the update, editors of Canada’s Top 100 Employers organize the annual competition that recognizes exceptional workplaces in Canada’s four Atlantic provinces. Criteria for evaluating employers include physical workplace, work atmosphere, performance management and training, skills and development. “We’re proud to accept this award, which demonstrates our exceptional teams’ ability to manage rapid growth while ensuring employee satisfaction, skills training and a vibrant company culture are priorities for the organization,” Organigram CEO Greg Engel said in the news release.

To view the full press release, visit http://cnw.fm/cvL37

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).  For more information, visit the company’s website at www.Organigram.ca.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Ships First Wave of Vaporizer Offerings

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced release of the first of its ‘Cannabis 2.0’ products, including Trailblazer Spark, Flicker and Glow 510-thread Torch vape cartridges.  According to the update, shipments of the custom-designed cartridges were sent to Manitoba, Saskatchewan, Ontario, New Brunswick and Nova Scotia, starting December 17, from the Company’s Moncton production campus. “As a company, bringing the next-generation of cannabis products to market without delay was important to us. We are proud to support access to tested, quality derivative-based products that we expect to help strengthen the regulated market and benefit those who prefer those product types over others,” Organigram CEO Greg Engel said in the news release. “Being one of the first licensed producers in the country ready to provide vape products, following the expiration of Health Canada’s 60-day notification period, illustrates that degree of focus and commitment. It speaks to an extraordinary effort by our internal teams who helped bring the Trailblazer Torch to market.”

To view the full press release, visit http://cnw.fm/aC42I

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).  For more information, visit the company’s website at www.Organigram.ca.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Receives Health Canada Approval for Licensing of 16 Additional Cultivation Rooms Under Cannabis Regulations

Organigram Holdings (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “company” or “Organigram”), a leading licensed producer of cannabis, today announced the company’s receipt of Health Canada’s approval for the licensing of 16 additional cultivation rooms under the Cannabis Regulations. According to the update, the expanded license was effective as of December 12, 2019, and the new cultivation rooms represent approximately 13,000 kg/yr1 of increased target cultivation capacity. “This is a dynamic time for Organigram and the industry as a whole. Cannabis 2.0 – the legalization of adult use recreational cannabis edibles, vape products, extracts and topicals – is a new era for cannabis here at home and around the world,” Organigram CEO Greg Engel said in the news release. “Our physical expansion reflects our ambitious response to this new opportunity as well as our ongoing commitment to anticipating and meeting the demands of Canadian cannabis consumers for new and innovative cannabis experiences.”

To view the full press release, visit http://cnw.fm/hQ8gF

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Organigram.ca.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Cannabis Legalization Opponents Admit Federal Policy is Blocking Research

Apart from marijuana legalization advocates, Friends of the National Institute on Drug Abuse (FNIDA) have also recognized that the federal authorities’ restrictions on marijuana are inhibiting cannabis research. FNIDA also raised the issue of federal limitations to Congress.

FNIDA submitted a proposal to a Senate committee on federal restrictions indicating that the status of marijuana and other drugs on the controlled substances list is inhibiting researchers from conducting studies on the drugs.

The group (FNIDA) also requested a federal agency, NIDA, to release a report containing all the research hurdles associated with the controlled substance status of cannabis.

In a new document published by the Senate, FNIDA describes itself as a coalition of more than 150 scientific and research communities, patient groups, and other organizations whose commitment is to prevent and treat drug use disorders.

The group aims to have the Department of Labor, Health and Human Services, as well as the Department of Education and related agencies adopting their language in the financial report for the year 2019. The recommendations made by FNIDA were published earlier this month by the Government Publishing Office, although it is not certain when they submitted their statement.

FNIDA is concerned that the federal restrictions are hindering research on drugs classified as Schedule 1, such as cannabis or its compounds. Currently, we need every information regarding the drugs, and instead of heaping on the restrictions, the agency should be lowering them and other hurdles inhibiting scientists from conducting research. The Appropriations Committee directed NIDA to write a report on the barriers to research on drugs and components that are classified as controlled substances.

Some members of FNIDA, such as Kevin Sabet, publicly challenged the letter submitted to the Senate. Sabet argued that rescheduling of the drug is not a must to supporting research efforts. Kevin Sabet is the president of Smart Approaches to Marijuana; he also serves on the group’s Board of Scientific Advisors.

In 2015, Sabet’s group said that drug rescheduling would not solve the challenge for the need for more research on the drug; instead, it would encourage the illicit operators to continue manufacturing poor quality products.

Sabet wrote in the Huffington Post that reclassifying marijuana would only serve as a victory to marijuana advocates as it would be distracting and meaningless.

In a law review article submitted in 2013, Sabet argued that for legitimate marijuana research to proceed, it is not a must for marijuana to be rescheduled because the Schedule 1 status of weed does not prevent it from being tested and studied for medical purposes. However, Sabet did not acknowledge the fact that the research programs can be delayed by restrictions laid out on Schedule 1 substances.

Bertha Madras commended the DEA (Drug Enforcement Administration) for rejecting the petition for rescheduling pot. She further said that it would be unethical to move marijuana to Schedule II of controlled substances.

In April, NIDA Director Nora Volkow said that it becomes difficult to research once drugs are classified as Schedule I, which is usually done to protect the public.

This news is likely to be welcomed by the marijuana industry, including Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) and Marijuana Company of America Inc. (OTCQB: MCOA), since the growing consensus that marijuana’s current scheduling is a barrier to research will pile pressure on the federal authorities to revise this classification eventually.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Announces Establishment of At-The-Market Equity Program

Organigram Holdings (NASDAQ: OGI) (TSX: OGI) today announced that it has established an at-the-market equity program (“ATM Program”) that allows the corporation, at its discretion, to issue up to C$55,000,000 (or its U.S. dollar equivalent) of common shares from treasury to the public from time to time. Any common shares sold in the ATM Program will be sold through the Toronto Stock Exchange, the NASDAQ Global Select Market or any other marketplace on which the common shares are listed, quoted or otherwise traded, at the prevailing market price at the time of sale. The corporation, at its sole discretion, will determine the volume and timing of distributions under the ATM Program, if any.

To view the full press release, visit http://cnw.fm/fk7Sd

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select Market and a Toronto Stock Exchange (“TSX”) listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the company is regulated by Health Canada under the Cannabis Act (Canada) and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Organigram.ca.

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://cnw.fm/OGRMF

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Announces Q4 and 2019 Fiscal Year Results

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its results for the fourth quarter and fiscal year ended August 31, 2019 (“Q4” or “Q4 2019”). Among the highlights, Organigram reported a 547% growth in 2019 net revenue to $80.4 million from $12.4 million in 2018, and a 575% increase in 2019 gross margin, before fair value changes to biological assets and inventory, to $37.9 million or 47% of net revenue from $5.6 million or 45% of net revenue in 2018. “Our 2019 results reflected a successful year for Organigram. Not only did we report strong top-line growth and establish an enviable national market share position in Canada, we generated positive adjusted EBITDA – one of the key measures we use to evaluate our performance,” Organigram Chief Executive Officer Greg Engel said in the news release. “In 2019, we increased staffing and capacity to meet forecasted demand and maintain inventory in the market. Industry structural issues have challenged supply and demand dynamics in the short-term but we believe the growth opportunity in the Canadian cannabis market remains intact.”

To view the full press release, visit http://cnw.fm/GS2eh

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select Market and a Toronto Stock Exchange (“TSX”) listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the company is regulated by Health Canada under the Cannabis Act (Canada) and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Organigram.ca.

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://cnw.fm/OGRMF

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Minnesota Marijuana Legalization Advocates Take Lessons from Colorado

This week, former Colorado public officials Stanley Garnett and Doug Friednash, who were opposed to marijuana legalization, shared their opinions with Minnesota legislators about the things to consider if cannabis is to be legalized.

The two are currently members of a Denver law firm with a department dealing with marijuana and industrial hemp. They said that they are sure they made the right decision by opposing legalization. At the time of their speech, they were invited to Minnesota by Ryan Winkler, who is the Minnesota House Majority Leader. Winkler is heading the cannabis legalization initiative in Minnesota.

The two said that the reason they accepted the invitation was to express their fears on the legalization of adult-use weed and regulations if Minnesota moves forward with the initiative. Friednash, who is the former chief of staff to Colorado’s Governor John Hickenlooper, said that other states that opt to follow Colorado could learn from their experience.

Friednash went on to say that the process of legalization was scary because no other state had done it and were afraid of the implications since they were being watched internationally.

Garnett, who served as the district attorney in Boulder County for three terms, said that he was in favor of adult-use marijuana prohibition before the voter approval in 2014.

Garnett has had a change of heart because he is now in favor of recreational marijuana legalization, as it ensures public safety. He noted that Colorado’s experience with marijuana has revealed that with proper rules in place, legalization is better than criminalization.

Garnett further said that he was initially doubtful of the success of the 2012 referendum in Colorado which required legislators to allow for the legal cultivation, possession, use, and sale of cannabis to adults.

Garnett also said that marijuana prohibitionists claimed that the legalization of adult-use pot would lead to the collapse of the western civilization because of increased crime rates, deaths, as well as deterioration of public safety. But, none of these have happened since legalization.

In Minnesota, they have a medical cannabis program that permits patients with a limited set of illnesses to use marijuana. The drugs can be accessed only in the form of a pill, oil, or vapor.

Winkler, together with other broader marijuana advocates, are drafting a bill for the next legislative session and the majority of the Democrats are in favor but the Republicans are against the legalization of marijuana for non-medicinal use. He says that they aim at creating a legal and regulated market while still enforcing action against illegal activities such as underage use and the black market.

The two officials also attended other functions during their stay in Colorado, such as the citizen meeting at the town hall, and they also met with leaders of the Minnesota Police and Peace Officers Association (MPPOA).

The Executive Director of MPPOA, Brian Peters, appreciated the Colorado officials’ willingness to talk about the challenges they faced during legalization.

Friednash said that states need to change the packaging and labeling of edibles to make them less attractive to children. He also noted that stringent control of plant products should be implemented.

Friednash further said that before licensing, the state has to consider agricultural, revenue, and public safety impacts in addition or marijuana’s effects on the education system and human rights.

Industry watchers say cannabis entities like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) could be pleased that the Minnesota lawmakers opted to listen to both sides of the legalization debate from the perspective of Colorado.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – What Women Should Know About Marijuana and Breast Cancer

Breast Cancer Awareness is held in the month of October. Chances are, you know someone who has been diagnosed with breast cancer. According to U.S. breast cancer statistics, there is a probability that one in eight women in America will develop breast cancer over their lifetime.

The Centers for Disease Control and Prevention states that not factoring in other types of cancers, the most common type of cancer among women in the U.S is breast cancer. It does not discriminate on race or ethnicity, and anyone can develop breast cancer.

Women can now use marijuana to manage the side effects and pain caused by breast cancer treatment. Listed below are the benefits of using medical marijuana for breast cancer:

  • Eases pain by reducing inflammation.
  • Manages chemotherapy side effects such as nausea and vomiting.
  • Stimulates appetite suppressed by rounds of chemotherapy.
  • Relieves anxiety.
  • Induces relaxation thus stimulating sleep.
  • It inhibits the growth of cancer cells and reduces the size of the tumor.

It is essential to understand that women and men’s health differ; therefore, the medical community has tried to develop treatment tailored to meet the needs of each individual instead of thinking one size fits all.

Cannabinoid receptors in women are sensitive, especially those located in the uterus, and since they are concentrated, they help in relieving pain, regulating mood, improving appetite, and inducing sleep more effectively than in men. Also, women require lower doses of marijuana because the presence of cannabinoid receptors enables their bodies to absorb marijuana quickly and efficiently. This provides them with better pain relief and management of other symptoms they may experience.

The regular use of marijuana can lead to marijuana tolerance, and this would require women to up their dosage over time.

The menstrual cycle causes estrogen levels to fluctuate, which makes women more sensitive to the effects of marijuana. Therefore, they should adjust the doses according to the level of the estrogen to achieve the desired impact. For example, lower doses should be taken around ovulation when estrogen is highest.

Hormonal therapy is prescribed for women to slow the growth and spread of breast cancer cells. This therapy can either add or remove hormones, which eventually affects the body’s response to marijuana. A recent study on cannabis that used animal subjects shows that CBD, one of the compounds found in marijuana, helps to shrink breast cancer cells and reduce tumor growth.

Experts think that different groups of patients need specialized information to help them understand how medical marijuana can be of help to them, and that could be the reason why marijuana companies like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) emphasize the provision of information so that customers make informed decisions when selecting products.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Bill Filed in Illinois to Give Marijuana Industry Greater Access to Banking Services

Last week, an Illinois lawmaker filed a bill that would increase access to banking services for marijuana businesses. The number of financial institutions accepting to transact with marijuana-related businesses is increasing; however, the majority are still wary of doing business with cannabis businesses while cannabis remains federally illegal.

Now new legislation that would create a licensing process for banks and credit unions has been introduced by Democratic Representative Kambium Buckner. The bill would allow financial institutions to accept and issue special purpose checks for cannabis businesses.

The new legislation coincides perfectly with the comprehensive marijuana legalization bill, signed by the Illinois governor, which is set to take effect on January 1, 2020.

Although the legislation would have no effect on federal marijuana policy, it would help mitigate the risks that are faced by marijuana businesses operating on a cash-only basis by allowing licensed financial institutions to accept alternative methods of payments.

The new legislation assigns the responsibility of issuing the licenses to the Cannabis Banking and Credit Union Advisory Board.

The provisions of the bill include providing a safe and fast way to pay state and local fees and taxes, facilitating the payment of rent associated with marijuana business account holders as well as issuance of special purpose checks. The board would also have to invest in the state’s economy legally and reduce the burden of collecting and managing large sums of money from the local government.

Individuals or entities that have received limited marijuana charters or credit unions are expected to follow the Federal Bank Secrecy Act. They are also required to comply with the reporting guidelines for the Financial Crimes Enforcement Network.

The special purpose checks issued by the financial institutions can only be issued for the specific tasks as stipulated in the legislation. For example, paying off local and state taxes, rent, and issuing of bonds or warranties would only be allowed through these checks.

Marijuana limited charter banks and credit unions can form a network by entering into a contract. But, this would not prevent them from providing financial services to other businesses other than cannabis businesses.

The introduction of the new legislation finds Congress deep in the bipartisan legislation debates, which are meant to protect banks from being penalized by the federal regulators for transacting with marijuana businesses across the legal states. The SAFE Banking Act, which was approved by the House in September, is expected to secure Senate Banking Committee approval before the end of 2019.

In an interview with an online industry publication last week, the panel chairman, Senator Mike Crapo said that he is in support of holding a committee vote in the near future. But, he is suspicious of the House impeachment proceedings that could delay the marijuana banking vote.

Experts are of the view that cannabis businesses like ChineseInvestors.com (OTCQB: CIIX) and Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) may be hoping that this Illinois bill is enacted so that cannabis businesses can access some banking services.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.